← Research.Patient.info

Browse research by condition

8,530 conditions with active clinical research. Pick a condition to see every study we've indexed and find those still recruiting.

#

1. Patients with compensated liver cirrhosis due to any underlying liver disease with advanced fibrosis (F4) and hepatic impairment that meets the criteria for Child-Pugh A 2. Patients with decompensated liver cirrhosis due to any underlying liver disease with advanced fibrosis (F4) and hepatic impairment that meets the criteria for Child-Pugh B2
18F-FDG PET/CT1 recruiting1
(Ph+) Chronic Myeloid Leukemia1
4 Weeks Supplementation of Huel Ready to Eat Foods1
Exocrine Pancreatic Insufficiency1
0001
- polyarthritic forms of severe1
- severe recalcitrant disabling psoriasis which is not adequately responsive to other forms of therapy and severe psoriatic arthritis in adult patients1
- mild-to-moderate Crohn’s disease1
(HR) -positive human epidermal growth factor receptor 2 (HER2) -negative breast cancer (BC)1
2008)1
2008) guideline1
"Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)1
18-64 years old volunteers with general good health1
000 CFU in adults over 60 years of age.1
65% of them will die within 5 years. The only curative treatment is surgery with complete resection of the primary tumor. However1
-Peripheral neuropathy clinically defined: *Pure sensitive (lymph node disease) or sensorimotor neuropathies *Proved EMG1
-Primary Sjögren's syndrome defined as per the European and American criteria1
"Ph1: •Locally advanced (LA) or metastatic MTAP-deleted (met.MTAP-del.) solid tumors •MTAP-del.relapsed or refrac. Grade 4 astrocytoma or glioblastoma multiforme (R/R GBM) Ph2: A1:LA or met.MTAP-del. squamous and nonsquamous NSCLC A2:LA or met.MTAP-del. mesothelioma A3:LA or met.MTAP-del. sarcoma A4:LA or met.MTAP-del. pancreatic ductal adenocarcinoma or adenosquamous carcinoma w/predominantly adenocarcinoma histology A5:Other LA or met.MTAP-del. solid tumors A6:MTAP-del. R/R GBM"1
#2:Relapsed/refractory diffuse large B-cell lymphoma1
#3:Progressive1
#4:Relapsed/refractory cutaneous T-cell lymphoma1
#5: Other tumor types that may have sensitivity to ASTX6601
# 6: Cervical carcinoma not responsive/relapsed after standard therapy1
5) avec dysurie modérée à sévère (score IPSS > 7) par dyssynergie vésico-sphinctérienne authentifiée au bilan urodynamique complet.1
- Locally advanced or metastatic solid tumors - Cholangiocarcinoma - Skeletal chondrosarcoma - Low-grade glioma - Any other solid tumor harboring an IDH mutation1
- Acute myeloid leukemia - Myelodysplastic syndrome/ Myeloproliferative neoplasm - Angio-immunoblastic T-cell lymphoma - Other mIDH-positive hematological malignancies (other than tumor types mentioned above)1
- Either ypT0-2 ( all TRG grade) or ypT3 (with TRG 1a-b according to Becker classification or TRG1-2 according to Mandard’s classification)1
2 or 3a patients.1
"Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium avium Complex (MAC)"1
000 people may be affected by HCM1
95% CI 4.6-10.7]1
95% CI 1.6-4.6)1
95% CI 1.3-21
3) and all-cause mortality (RR 2.51
95% CI 1.8-3.4) with a mean follow-up of 7 years. Hence1
8th edition) non-small cell lung carcinoma (NSCLC)1
"Patients with interstitial lung disease associated pulmonary hypertension"1
Solid tumor cancer and lung cancer1
2017)1
18 driven monogenic autoinflammatory conditions: NLRC4 mutation and XIAP deficiency1
"Non-Alcoholic Steatohepatatis (NASH) is the progressive form of Non-Alcoholic Fatty Liver Disease (NAFLD)with a prevalence of approximately 2% to 3% of the general population. Non-alcoholic steatohepatitis can lead to cirrhosis and its complications1

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y